A diagnosis of serious liver disease can feel like a slow countdown. Scar tissue builds quietly, the liver stiffens, and the ...

A new study from the Hebrew University of Jerusalem suggests that non-intoxicating cannabis compounds CBD and CBG may help ...

GSK’s linerixibat is currently under regulatory review in the US, Europe, and China, amongst other regions.

CBD and CBG, two non-intoxicating cannabis compounds, may help combat fatty liver disease by boosting liver energy reserves ...

CBD and CBG may help the liver recharge and clean itself—offering a promising new plant-based strategy against fatty liver disease.

March 9 (Reuters) - GSK said on Monday it will receive up to $690 million from Italian pharmaceutical company Alfasigma for ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) can cause more serious liver conditions, such as liver failure. A new study, led by Lund University in Sweden, presents new data that ...

The British pharma giant will hand off its experimental itch treatment to Italian company Alfasigma as it focuses on broader ...

Fatty liver disease happens when too much fat builds up in the liver. Metabolic dysfunction-associated steatohepatitis (MASH) is a severe type of fatty liver disease where fat buildup causes liver ...

A new experimental compound may help protect the liver after surgical removal of parts of the small intestine.

Liver cancer, primarily hepatocellular carcinoma, originates in the liver, with hepatitis B and C as major risk factors. Diagnosis involves physical exams, blood tests, imaging, and possibly biopsy to ...

JURUPA VALLEY, CA - March 05, 2026 - PRESSADVANTAGE - Resurgence Alcohol & Drug Rehab Riverside has published a new ...